SPY760.61+1.43%QQQ692.35+2.61%BTC/USD74,335.55+0.87%DIA524.33+0.50%GLD365.24−1.12%TLT80.91+0.04%

Ocugen Inc

OCGNNASDAQ

Trade with Public

$0.9571

0.00710.75%

Last update: Nov 11, 2:50 PM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Earnings: Q3 2026 Earnings were released on Wed Nov 4th, before the market open

Conference Call: The most recent conference call started at 8:30 AM, 7 days ago

Click to view the webcast

Ocugen (OCGN) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Ocugen (OCGN) stock.

Analyst Consensus — 5 Analysts

5Buy

# Analysts5

Latest Upgrades and Downgrades for Ocugen Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	HC Wainwright & Co.	Swayampakula Ramakanth	PT Cut	Buy	$10→$10
—	Canaccord Genuity	Whitney Ijem	PT Cut	Buy	$12→$11
—	Chardan Capital	Daniil Gataulin	Maintained	Buy	$7
—	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$7→$10
—	Canaccord Genuity	Whitney Ijem	Initiate	Buy	$12
—	Oppenheimer	Leland Gershell	Initiate	Outperform	$10
—	Chardan Capital	Daniil Gataulin	Maintained	Buy	$7
—	Chardan Capital	Daniil Gataulin	Maintained	Buy	$7
—	Chardan Capital	Daniil Gataulin	Maintained	Buy	$7
—	Chardan Capital	Daniil Gataulin	Maintained	Buy	$7
—	Chardan Capital	Daniil Gataulin	Maintained	Buy	$7
—	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$7
—	HC Wainwright & Co.	Swayampakula Ramakanth	PT Cut	Buy	$8→$7
—	Chardan Capital	Daniil Gataulin	Maintained	Buy	$7
—	Chardan Capital	Daniil Gataulin	PT Raise	Buy	$6→$7
—	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$8
—	Chardan Capital	Daniil Gataulin	Maintained	Buy	$6
—	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$7→$8
—	Chardan Capital	Daniil Gataulin	Maintained	Buy	$6
—	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$7

Ocugen Inc

Ocugen (OCGN) Stock Price Target 2026

Latest Upgrades and Downgrades for Ocugen Stock

Ocugen (OCGN) Stock Price Target 2026

Latest Upgrades and Downgrades for Ocugen Stock

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

PRO
Canaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

PRO
Canaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

PRO
Oppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10

People Also Watch

People Also Watch

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

PRO
Canaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

PRO
Canaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

PRO
Oppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10

Ocugen Inc

Ocugen (OCGN) Stock Price Target 2026

Latest Upgrades and Downgrades for Ocugen Stock

Ocugen (OCGN) Stock Price Target 2026

Latest Upgrades and Downgrades for Ocugen Stock

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

PROCanaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

PROHC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

PROCanaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

PROOppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10

People Also Watch

People Also Watch

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

PROCanaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

PROHC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

PROCanaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

PROOppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

PRO
Canaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

PRO
Canaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

PRO
Oppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

PRO
Canaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

PRO
HC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

PRO
Canaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

PRO
Oppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10